Gyn Flashcards
Oral Boards
Staging Cervical Cancer:
Stage I?
Stage II?
Stage III?
Stage IA1 stromal invasion <=3mm
IA2 invasion >3mm and <=5mm
Stage IB1 lesion limited to the cervix uteri with size measured by maximum tumor diameter
IB1 >5mm and <=2cm
IB2 >2 to <=4cm
IB3 >4cm
IIA Involvement limited to the upper two-thirds of the vagina without parametrial invasion
Stage IIA1 Invasive carcinoma ≤4 cm in greatest dimension
IIA2 Invasive carcinoma >4 cm in greatest dimension
IIB Parametrial invasion
IIIA Carcinoma involves lower third of the vagina, with no extension to the pelvic wall
IIIB Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney
IIIC1 Pelvic lymph node metastasis only
IIIC2 Paraaortic lymph node metastasis
Workup for Cervical?
History
Initial/urgent concerns:
Vitals, bleeding, transfusion
Symptoms (pelvic/back pain, post-coital bleeding, urinary or anorectal sx c/f fistula)
PMH: prior pap smears, STD Hx, Immunodeficiency (HIV, solid organ transplantation), inflamm bowel disease
Social: Multiple sexual partners (>10) as RF, Smoking, future desired fertility
Physical exam
Nodal exam
Full pelvic exam: Speculum, Bimanual, rectovaginal
assess tumor size, vaginal, parametria & sidewall involvement (RV)
Place fiducial at distal extent of vaginal disease
Cervical biopsy
Nodes generally not biopsied when treating as locally advanced due to primary
Labs – CBC, CMP (*renal function), pregnancy test, consider HIV
Imaging for IB1 and above
Pelvic MRI
PET/CT
Cystoscopy/proctoscopy + biopsy if concern for bladder/rectal invasion
NCCN: Consider EUA, cystoscopy, proctoscopy for stage IB3 or greater
**Before treatment: **
Diverting colostomy if rectal invasion
Nephrostomy tubes if hydronephrosi
Who can get fertility sparing? Hysterectomy? Who needs pelvic LND or SLNB?
Cervix
1) up to IB2
2) <=4c (IB2 and IIA)
3) Everyone except IA1 no LVSI.
Types of hysterectomies?
Class I for Stage IA1(no LVI) total, extrafascial
Removes uterus, cervix, small rim of vaginal cuff.
Class II for Stage IA1 (+LVI/Stage IA2) modified radical
Uterus, cervix, 1-2 cm vag cuff, resect parametrial/paracervical tissue medial to ureters
Class III for Stage IB1+: “Radical”
Resect parametrial tissue to pelvic sidewall and upper 1/3-1/2 of vagina
Should be OPEN (improved OS vs min invasive)
SEDLIS criteria
Adj RT in cervical?
Presence of any two out of three intermediate risk factors:
LVSI (positive).
Deep stromal invasion (outer 1/3 of cervical stroma).
Large tumor size (commonly ≥4 cm, though thresholds like ≥2 cm are sometimes considered).
45Gy IMRT to reduce LRR 30% to 15%.
PETERS Criteria
+LN, +margin, +parametria
45Gy+Cis (40mg/m2) increase OS 71% to 81%.
When would you give brachy post-op in cervical cancer? What reigmen?
NCCN: pos/close (<5mm) margin
Adjuvant EBRT 45 Gy using IMRT, + HDR 6 Gy x 3 to surface (NCCN)
In cervical cancer what is the pelvic LN involvment riks? PA LN involvment risk? 5 yr OS?
1) Pelvic LN risk is stage x15ish
2) Stage x 10ish
3) 100-Pelvic LN risk %
Describe volumes for intact cervix?
CTV_1: GTV, cervix, entire uterus
CTV_2: Parametria, superior vagina (2cm below more inferior extent)
CTRV_3: Common, and internal/external iliac, obturator, and presacral nodes (7mm brush)
PTV expansions: 15mm for CTV1, 10mm for CTV2, 7mm for CTV3. Or just use bladder full and empty ITV and 7mm for everything.
*if common iliac or PA node involved field to renal vein or 2cm above disease.
Gyn Pelvic Constraints for:
1) Rectum
2) Bladder
3) Bowel Bag
4) Duodenum
5) Femoral Head
6) Kidney
7) Spinal Cord
8) Bone Marrow
1) Rectum: V45<50%
2) Bladder: V45<50%
3) Bowel Bag: V40<30%
4) Duodenum: V55<15cc
5) Femoral Head: V30<15%, dmax 115%
6) Kidney: Mean <15Gy
7) Spinal Cord: Dmax <48Gy
8) Bone Marrow: V20<75%, V10<90%
9) Ovaries: <5Gy
What is point A and B?
What is Point A?
Along the tandem 2 cm superior to the flange and 2 cm lateral
Approximates parametria and ~ where the uterine artery/ureter cross
What is Point B?
Along midline 2 cm superior to the flange/cervical os and 5 cm lateral
Approximates pelvic sidewall/obturator nodes
1/3rd – ¼ of Pt A dose
Brachy OAR contraints for Gyn?
Bladder: D2cc <90
Rectum, Sigmoid, Bowel, Recto-vaginal point: D2cc <75cc
Acute and late toxicity for Gyn RT?
Acute: fatigue, diarrhea, dysuria, urinary frequency, skin irritation, hemorrhoid irritation
Late: vaginal atrophy/stenosis, sexual dysfunction, menopause, alteration in bowel/bladder fxn
* Severe late: recto-sigmoid stenosis, fistula, bleeding (rectum/bladder), pelvic insufficiency fracture (10-15%), second malignancy
* Risk of late G3+ severe toxicity < 10% (most < 5%)
Walk through FIGO staging for endometrial cancer (2009)
IA: < 1/2 MM
IB >=1/2 MM
II invades cervix but not beyond uterus (does NOT Include endocervical glandular tissue)
IIIA serosa or adenixa
IIIB vaginal involvment or parametrial involvment
IIIC1 regional node mets
IIIC2 PA nodes
What the molecular subgroups in endometrial cancer? How might it change managment per ASTRO but not yet used by NCCN?
PORTEC-1 and GOG-99 HIR?
High int (GOG): age ≥70 w/ 1 RF; age 50-69 w/ 2 RFs; or age 18-49 w/ 3 RFs (RF=deep 1/3rd MMI, G2-3, LVI)
High int (PORTEC): 2 of 3 RFs (age > 60, MMI > 50%, G3)
Walk me through VBT. When do you add it to EBRT?
6-8 wks post-op (12 wks max)
Perform pelvic examination to ensure the cuff is healed
Radio-opaque seeds are placed at the top of the vaginal cuff at 9:00 and 3:00
Place the largest diameter cylinder that can comfortably fit (2.5-3.5cm)
Ensure snug fit and securement
CT simulation, planning:
Target upper 3 – 5 cm for endometrioid
Target upper 2/3 for type II histology, extensive LVSI, vaginal involvement, +SM
Daily imaging to verify placement before treatment
7 Gy x 3 Fx prescribed to 5 mm (more fibrosis)
*Add after EBRT if stage II (cervical involvment): 6Gy x 2-3 to surface.
RT tx recs for stage I-II endometrial?
How do you treat stage I-II HR histologies (clear cell, serous, carcinosarcoma, dediff or undiff carcinoma.
Stage IA VBT+chemo, Stage IB/II chemo+EBRT
5yr OS for endometrial adeno?
St I 90% +
St II 80-90%
St III 70-80% (lower for HR histology, p53 mut)
How do you treat inoperable endometrial cancer? RT dose and goal EQD2?
Definitive RT: WPRT + brachy as standard
WPRT: 45 Gy
Intracavity HDR brachytherapy
Tandem + vaginal cylinder
5Gy x 5 to CTV = uterine serosa, cervix, upper 1-2cm vagina
Goal EQD2 to GTV: 80-90Gy
Goal EQD2 to CTV D90: 65-75Gy
If stage I grade 1-2 with superficial or minimal myometrial invasion on MRI
Brachytherapy alone
7.3 Gy x 5 to CTV = uterine serosa, cervix, upper 1-2cm vagina
Goal EQD2 to GTV: 80-90 Gy
Goal EQD2 to CTV D90: 48-62.5 Gy
How do you treat vaginal cuff recurrence for endometrial cancer?
If no prior XRT:
WPRT: 45Gy
Vaginal cylinder (<5mm thickness) or interstitial brachytherapy boost (>5mm)
Many use Syed template (if you are not familiar with this, say refer to a center with IS brachy experience
5Gy x5 to cover lesion
HR-CTV: GTV-residual + any thickening/irregular mucosa w/in original tumor extent
Goal EQD2 ~80 Gy. Consider lower ~70 Gy lower vagina (due to tolerance)
If prior RT, surgical exploration and/or systemic therapy. If previous EBRT then brachytherapy +/- systemic therapy.
FIGO staging for Vulvar Cancer?
IA Tumor <=2cm and stromal invasion <=1mm
IB Tumor >2cm or stromal invasion >1mm
II Extension to lower 1/3 of urethra, vagina, anus (N0)
IIIA Tumor size extension to upper 2/3 of the urethra, vagina, bladder mucosa, rectal mucosa, or regional LN mets <=5mm.
IIIB LN mets >5mm
IIIC LN mets with ECE
IVA Disease fixed to pelvic bone, ulcerated regional LNs
IVB Distant mets
*Regional = inguinal & femoral. Pelvic nodes = DM
Which vulvar patients can get SLNBx? Who need bilateral nodes evaluated?
Criteria for SLNbx in lieu of ILND:
* Tumor < 4 cm
* cN0
* No prior vulvar surgery which may affect lymphatic drainage
Address bilateral nodes for:
Tumor < 2 cm from vulvar midline, > 4 cm, or clinically positive node (biopsy confirmed)